Compounded Semaglutide Dosing Schedule

Same active ingredient as Wegovy® Same active ingredient as Ozempic®
Click Here to Get Started →
Compounded Semaglutide vial
Compounded Semaglutide
Phase Duration Dose Administration
Initial 4 weeks 0.2 mg Once weekly
Dose Escalation 4 weeks 0.4 mg Once weekly
Therapeutic 4 weeks 0.9 mg Once weekly
Maintenance Ongoing 1.5 mg Once weekly
Maximum Ongoing 2.0 mg Once weekly
$149 (Initial 0.2mg dose)
$249/month (Dose Escalation through Maximum)
Compounded by partner pharmacy
Note: Compounded medications are prepared by licensed pharmacies and may differ from brand-name formulations. Compounded medications are not FDA approved.
*First month at $149 for 0.2mg starter dose. Standard titration schedule shown. Individual dosing may vary based on provider recommendation. Prices subject to change. All prices include 4-week supply. Additional fees may apply. Compounded semaglutide formulations may contain additional ingredients like B12.

GLP-1 Medication Comparison
(Injectables)

Medication Type Cost Avg Weight Loss*** How It Works Dosing Common Side Effects
Semaglutide (Wegovy®) GLP-1 agonist $$$ 15% Mimics GLP-1 hormone to reduce appetite and slow digestion Weekly Nausea, diarrhea, constipation
Semaglutide (Ozempic®) GLP-1 agonist $$$ 15% Mimics GLP-1 hormone to regulate blood sugar and reduce appetite Weekly Nausea, vomiting, diarrhea
Liraglutide (Saxenda®) GLP-1 agonist $$$ 10% Activates GLP-1 receptors to increase fullness and reduce hunger Daily Nausea, headache, dizziness
Tirzepatide (Zepbound®) GLP-1/GIP agonist $$ 20% Dual-action: targets both GLP-1 and GIP receptors for enhanced appetite suppression Weekly Nausea, diarrhea, constipation
Tirzepatide (Mounjaro®) GLP-1/GIP agonist $$$ 20% Dual-action: targets both GLP-1 and GIP receptors for blood sugar control and weight loss Weekly Nausea, vomiting, diarrhea
Compounded Semaglutide** GLP-1 agonist $ 15% Same mechanism as branded semaglutide (not FDA-evaluated) Weekly Similar to branded (varies by pharmacy)
Compounded Tirzepatide** GLP-1/GIP agonist $ 20% Same mechanism as branded tirzepatide (not FDA-evaluated) Weekly Similar to branded (varies by pharmacy)

This chart provides general information. Well Brain Body clinicians will help determine which option may be appropriate for your individual needs.